Study finds no correlation between ADHD gene, drug response

06/25/2008 | Forbes

Catechol-O-methyltransferase, a gene variant associated with attention-deficit/hyperactivity disorder, failed to help researchers identify patients who would most benefit from a class of drugs called methylphenidates, a Canadian study found. The findings may affect the treatment of pediatric ADHD patients and should be confirmed in other populations, one of the researchers said.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY